Viimane versioon :
28/04/2024
Infostab
Ingredientide nimekiri
Nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
Uurimisrühmad
Valistab
Plakat
Sidemed
Sponsorid
Autor
Kasutusjuhend
Ajakiri
Uurimisrühmad - Hospital General Universitario Vall d\'Hebron
Hospital General Universitario Vall d\'Hebron
Barcelone
Viited
(4)
1
Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia.
Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner ()
SEFH Congress (Virtual) October 2021 -
2021
-
2
Stability of amphotericin B in water solution for inhalation.
Juarez JC, ,Lopez RM, Hucto M et al. ()
Eur Hosp Pharm -
1997
- ; 3: 59-60.
3
Stability of cisplatin in sodium chloride 0.9% intravenous solution related to the container’s material.
Pujol Cubells M, Prat Aixela J, Girona Brumos V, Duran Pou S, Villaronga Flaque MV. ()
Pharm World Sci -
1993
- ; 15: 34-36.
4
Stability of famotidine 20 and 40 mg/L in total nutrient admixtures.
Montoro JB, Pou L, Salvador P, Pastor C, Cano SM. ()
Am J Hosp Pharm -
1989
- ; 46: 2329-2332.
Molekulid uuritud
(14)
Amphotericin B
Ampicillin sodium
Atosiban
Cisplatin
Clindamycin phosphate
Dexketoprofen
Famotidine
Gentamicin sulfate
Labetalol hydrochloride
Magnesium sulfate
Metamizol sodium
Metoclopramide hydrochloride
Omeprazole sodium
Paracetamol
Mentions Légales
